ClassID:

109145

C12N2310/14 - page 26 - CPC Classification

Classification description:

Structure or type of the nucleic acid; Type of nucleic acid interfering N.A.

Recent Application in this class:
#7501
20110229984
2011-09-22

Materials and methods directed to asparagine synthetase and asparaginase therapies

#7502
20110229966
2011-09-22

Nanoparticle-based gene delivery systems

#7503
20110229560
2011-09-22

NLRC5 AS A TARGET FOR IMMUNE THERAPY

#7504
20110229558
2011-09-22

AGENT FOR TREATING MYELOFIBROSIS

#7505
20110229557
2011-09-22

Double-stranded oligonucleotide compound for down-regulating the expression of CASP2 gene

#7506
20110229498
2011-09-22

COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE

#7507
20110229493
2011-09-22

Neuregulin antagonists and use thereof in treating cancer

#7508
20110229485
2011-09-22

INHIBITION OF THE NT-3:TRKC BOUND AND ITS APPLICATION TO THE TREATMENT OF CANCER SUCH AS NEUROBLASTOMA

#7509
20110229484
2011-09-22

Host cell kinases as targets for antiviral therapies against HCV infection

#7510
20110224418
2011-09-15

MODIFIED sIRNA MOLECULES AND USES THEREOF

#7511
20110224284
2011-09-15

PUTATIVE TUMOR SUPPRESSOR MICRORNA-101 MODULATES THE CANCER EPIGENOME BY REPRESSING THE POLYCOMB GROUP PROTEIN EZH2

#7512
20110224282
2011-09-15

iRNA agents targeting VEGF

#7513
20110224277
2011-09-15

Oligomeric compounds and compositions for use in modulation of small non-coding RNAS

#7514
20110224149
2011-09-15

Polynucleotides for use in treating and diagnosing cancers

#7515
20110223665
2011-09-15

ENHANCEMENT OF siRNA SILENCING ACTIVITY USING UNIVERSAL BASES OR MISMATCHES IN THE SENSE STRAND

#7516
20110223656
2011-09-15

MicroRNAs and Uses Thereof

#7517
20110223311
2011-09-15

Cottonseed oil and uses

#7518
20110223217
2011-09-15

Block copolymers and uses thereof

#7519
20110223204
2011-09-15

TREATMENT OF PAIN WITH GAP JUNCTION MODULATION COMPOUNDS

#7520
20110223171
2011-09-15

Methods and Compositions for the Diagnosis and Treatment of Cyclin A-1 Associated Conditions

#7521
20110223152
2011-09-15

Use of inhibitors of leukotriene B4 receptor BLT2 for treating human cancers

#7522
20110218334
2011-09-08

PHOSPHOROTHIOATE OLIGONUCLEOTIDES AND NON-NUCLEOSIDIC PHOSPHOROTHIOATES AS DELIVERY AGENTS FOR iRNA AGENTS

#7523
20110217769
2011-09-08

Cell-type specific aptamer-siRNA delivery system for HIV-1 therapy

#7524
20110217367
2011-09-08

Means for inhibiting the expression of Orc-1

#7525
20110217362
2011-09-08

Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof

#7526
20110217361
2011-09-08

Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof

#7527
20110217326
2011-09-08

Method for diagnosing and/or treating tumor

#7528
20110217274
2011-09-08

METHODS FOR PRODUCTION AND USES OF MULTIPOTENT ,PLURIPOTENT, DIFFERENTIATED AND DISEASE-RESISTANT CELL POPULATIONS

#7529
20110213016
2011-09-01

E2EPF Ubiquitin Carrier Protein-Von Hippel-Lindau Interaction and Uses Thereof

#7530
20110213015
2011-09-01

Oligonucleotidic sequences able to silence the expression of the chimera and uses thereof in medical field

#7531
20110213010
2011-09-01

Methods and compositions for the treatment of Huntington'S disease

#7532
20110213008
2011-09-01

Pharmaceutical containing HIF-1 alpha and HIF-2 alpha expression inhibitor

#7533
20110213007
2011-09-01

MicroRNAs and uses thereof

#7534
20110212520
2011-09-01

RNA interference suppression of neurodegenerative diseases and methods of use thereof

#7535
20110212081
2011-09-01

KRÜPPEL-LIKE FACTORS AND FAT REGULATION

#7536
20110212021
2011-09-01

TARGETED OLIGONUCLEOTIDE COMPOSITIONS FOR MODIFYING GENE EXPRESSION

#7537
20110209231
2011-08-25

TREATMENT AND PREVENTION OF INFLUENZA

#7538
20110207917
2011-08-25

SAM-6 VARIANTS, TARGET AND METHODS OF USE

#7539
20110207799
2011-08-25

Compositions for targeted delivery of siRNA

#7540
20110207796
2011-08-25

ALPHA-SYNUCLEIN KINASE

#7541
20110207795
2011-08-25

SMAD7 INHIBITOR COMPOSITIONS AND USES THEREOF

#7542
20110207625
2011-08-25

PIRNA AND USES RELATED THERETO

#7543
20110207224
2011-08-25

In vivo production of small interfering RNAs that mediate gene silencing

#7544
20110206689
2011-08-25

Molecular Determinants Associated With Prostate Cancer And Methods Of Use Thereof

#7545
20110206688
2011-08-25

Enhancing vessel lesion homing and repair potential of stem cells

#7546
20110206685
2011-08-25

SCREENING ASSAYS FOR INHIBITORS OF A STAPHYLOCOCCUS AUREUS SIDEROPHORE

#7547
20110206673
2011-08-25

POLYPEPTIDES AND POLYNUCLEOTIDES FOR ARTEMIN AND RELATED LIGANDS, AND METHODS OF USE THEREOF

#7548
20110201798
2011-08-18

Therapeutic compositions

#7549
20110201671
2011-08-18

Compositions and methods for inhibiting expression of a gene from the ebola virus

#7550
20110201670
2011-08-18

Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases

#7551
20110201668
2011-08-18

REGULATION OF NEUROTRANSMITTER RELEASE THROUGH ANION CHANNELS

#7552
20110201667
2011-08-18

Compositions and methods for silencing Ebola virus gene expression

#7553
20110200620
2011-08-18

B7-H1 and methods of diagnosis, prognosis, and treatment of cancer

#7554
20110200580
2011-08-18

Methods of treatment and prevention of diet-induced obesity and sequelae thereof

#7555
20110197293
2011-08-11

SENSE AND ANTISENSE TRANSCRIPTS OF TRPM2 AND USES THEREOF

#7556
20110197292
2011-08-11

Delivery method

#7557
20110196142
2011-08-11

DNA molecule for expressing Hairpin RNA, the constructing method and the use thereof

#7558
20110196016
2011-08-11

Compositions and Methods for Inhibiting Expression of IKK2 Genes

#7559
20110195411
2011-08-11

ARL-1 specific antibodies and uses thereof

#7560
20110195127
2011-08-11

Compositions and methods for silencing apolipoprotein B

#7561
20110195078
2011-08-11

TAT-BASED IMMUNOMODULATORY COMPOSITIONS AND METHODS FOR THEIR DISCOVERY AND USE

#7562
20110190445
2011-08-04

Inhibition of HRP-3 using modified oligonucleotides

#7563
20110190384
2011-08-04

siRNA specific to WT1 17AA(−)isoform and use thereof

#7564
20110190381
2011-08-04

RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma

#7565
20110190378
2011-08-04

miR 204, miR 211, their anti-miRs, and therapeutic uses of same

#7566
20110190377
2011-08-04

Method for producing a cell and/or tissue and/or disease phase specific medicament

#7567
20110190376
2011-08-04

RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA

#7568
20110190375
2011-08-04

COMPOSITIONS COMPRISING CMYC SIRNA AND METHODS OF USE THEREOF

#7569
20110190222
2011-08-04

Selective inhibition of polyglutamine protein expression

#7570
20110189776
2011-08-04

Prokaryotic RNAi-like system and methods of use

#7571
20110189766
2011-08-04

Micrornas and uses thereof

#7572
20110189300
2011-08-04

siRNA SILENCING OF APOLIPOPROTEIN B

#7573
20110189264
2011-08-04

Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof

#7574
20110189195
2011-08-04

Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl tRNA synthetase

#7575
20110189193
2011-08-04

CELL LINES AND HOST NUCLEIC ACID SEQUENCES RELATED TO INFECTIOUS DISEASE

#7576
20110189180
2011-08-04

Antigenic compositions and use of same in the targeted delivery of nucleic acids

#7577
20110184052
2011-07-28

ARGINASE II: A TARGET FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS

#7578
20110184050
2011-07-28

Methods and means for treating DNA repeat instability associated genetic disorders

#7579
20110184048
2011-07-28

Uses and compositions comprising miRNAs

#7580
20110184047
2011-07-28

RNAi modulation of SCAP and therapeutic uses thereof

#7581
20110184046
2011-07-28

Compositions And Methods For Inhibiting Expression Of GSK-3 Genes

#7582
20110184045
2011-07-28

SILENCNG AND RIG-I ACTIVATION BY DUAL FUNCTION OLIGONUCLEOTIDES

#7583
20110184041
2011-07-28

PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease

#7584
20110183912
2011-07-28

AGENT FOR PROMOTING NEURONAL DIFFERENTIATION AND METHOD THEREFOR

#7585
20110182980
2011-07-28

Composition for suppressing expression of target gene

#7586
20110182917
2011-07-28

Method for treating fibromyalgia

#7587
20110182916
2011-07-28

Use of Agonists of Integrin Alpha 5 for Inducing the Osteogenic Differentiation of Mesenchymal Stem Cells

#7588
20110182867
2011-07-28

Modulation of BCL11A for treatment of hemoglobinopathies

#7589
20110182865
2011-07-28

Method for Prophylaxis and Treatment of Equine Herpesvirus Type 1 Infections

#7590
20110178162
2011-07-21

Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy

#7591
20110178158
2011-07-21

Set of Antiangiogenic Molecules and Use Thereof

#7592
20110178157
2011-07-21

Modulation of HSP47 expression

#7593
20110178155
2011-07-21

Silencing of CSN5 gene expression using interfering RNA

#7594
20110177967
2011-07-21

Methods and compositions using splicing regulatory proteins involved in tumor suppression

#7595
20110177599
2011-07-21

DELIVERY OF NUCLEIC ACIDS ACROSS MEMBRANES

#7596
20110177571
2011-07-21

Designer calvin-cycle-channeled production of butanol and related higher alcohols

#7597
20110177160
2011-07-21

Amino acid lipids and uses thereof

#7598
20110177131
2011-07-21

siRNA SILENCING OF FILOVIRUS GENE EXPRESSION

#7599
20110177101
2011-07-21

TARGETING PAX2 FOR THE INDUCTION OF DEFB1-MEDIATED TUMOR IMMUNITY AND CANCER THERAPY

#7600
20110177100
2011-07-21

Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy

#7601
20110177099
2011-07-21

Genetic variations associated with drug resistance

#7602
20110177075
2011-07-21

TARGETING PAX2 FOR THE INDUCTION OF DEFB1-MEDIATED TUMOR IMMUNITY AND CANCER THERAPY

#7603
20110177054
2011-07-21

USE OF ENDO-LYSOSOMAL SYSTEM AND SECRETED VESICLES (EXOSOME-LIKE) IN TREATMENTS AND DIAGNOSTICS BASED ON SMALL RNA AND EXPERIMENTAL STUDY OF SMALL RNA

#7604
20110172291
2011-07-14

RNA interference for the treatment of gain-of-function disorders

#7605
20110172287
2011-07-14

Compositions and methods for inhibiting tumor growth and metastasis

#7606
20110172120
2011-07-14

Compositions and Systems for the Regulation of Genes

#7607
20110171730
2011-07-14

Conjugates For Use In Hepatocyte Free Uptake Assays

#7608
20110171287
2011-07-14

Use of Oligonucleotides with Modified Bases as Antiviral Agents

#7609
20110171221
2011-07-14

COMPOSITIONS AND METHODS FOR THE TREATMENT OF A NEOPLASIA

#7610
20110171184
2011-07-14

Method for Introducing a Pna Molecule Conjugated to a Positively Charged Peptide into the Cytosol and/or the Nucleus by Photochemical Internalisation (Pci)

#7611
20110171176
2011-07-14

Complement antagonists and uses thereof

#7612
20110166204
2011-07-07

Oligonucleotides of human endogenous retrovirus 9 (ERV-9) long terminal repeat (LTR) and methods of use

#7613
20110166203
2011-07-07

Anti-hepatitis C virus composition

#7614
20110166201
2011-07-07

miRNAs as therapeutic targets in cancer

#7615
20110166199
2011-07-07

RNAi compound targeted to thrombospondin-1 and applications thereof

#7616
20110166198
2011-07-07

RNA COMPOSITIONS FOR MODULATING IMMUNE RESPONSE

#7617
20110166065
2011-07-07

Modulation of glucose-6-phosphatase translocase expression

#7618
20110166058
2011-07-07

Organic compositions to treat HSF1-related diseases

#7619
20110165664
2011-07-07

TRANSFECTION DEVICE UTILIZING SERICIN

#7620
20110165227
2011-07-07

Compositions and methods using siRNA molecules for treatment of gliomas

#7621
20110165149
2011-07-07

Targeting ABCB5 for cancer therapy

#7622
20110165123
2011-07-07

5′ triphosphate oligonucleotide with blunt end and uses thereof

#7623
20110160707
2011-06-30

Compositions, devices and methods for treatment of Huntington's disease through intracranial delivery of sirna

#7624
20110160293
2011-06-30

PRMT1 for target genes of cancer therapy and diagnosis

#7625
20110160292
2011-06-30

Regulation of Integrin Surface Expression

#7626
20110160287
2011-06-30

Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof

#7627
20110160286
2011-06-30

Allele-specific RNA interference

#7628
20110160282
2011-06-30

NUCLEIC-ACID PHARMACEUTICAL COMPOSITION FOR CANCER THERAPY

#7629
20110160281
2011-06-30

RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA)

#7630
20110160280
2011-06-30

CANCER-RELATED GENES, CDCA5, EPHA7, STK31 AND WDHD1

#7631
20110160277
2011-06-30

Modulation of 11beta-hydroxysteriod dehydrogenase 1 expression for the treatment of ocular diseases

#7632
20110159586
2011-06-30

COMPOSITIONS AND METHODS FOR MODULATING GENE EXPRESSION USING ASYMMETRICALLY-ACTIVE PRECURSOR POLYNUCLEOTIDES

#7633
20110159010
2011-06-30

Compositions and methods for decreasing type III deiodinase activity to modulate adiposity and blood glucose levels

#7634
20110154520
2011-06-23

Vitamin K Epoxide Recycling Polypeptide VKORC1, a Therapeutic Target of Coumarin and Their Derivatives

#7635
20110152356
2011-06-23

RNAi therapeutic for treatment of hepatitis C infection

#7636
20110152353
2011-06-23

Double-stranded polynucleotide

#7637
20110152350
2011-06-23

Compositions and methods for inhibiting expression of XBP-1 gene

#7638
20110152349
2011-06-23

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF IL-18 GENES

#7639
20110152347
2011-06-23

Methods and compositions for controlling efficacy of RNA silencing

#7640
20110152345
2011-06-23

EBI3, DLX5, NPTX1 AND CDKN3 FOR TARGET GENES OF LUNG CANCER THERAPY AND DIAGNOSIS

#7641
20110151558
2011-06-23

METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS

#7642
20110151513
2011-06-23

SHRNA-MEDIATED INHIBITION OF EXPRESSION OF ALPHA-1,6-FUCOSYLTRANSFERASE

#7643
20110150936
2011-06-23

ANTI-TUMORAL CELLS

#7644
20110150899
2011-06-23

SENESCENCE CONTROL COMPOSITION CONTAINING EXTRACELLULAR MATRIX COMPONENTS, AND SENESCENCE CONTROL METHOD FOR SENESCENT CELLS USING SAME

#7645
20110150897
2011-06-23

INFLUENZA TARGETS

#7646
20110150894
2011-06-23

Methods of modulating angiogenesis via TRPV4

#7647
20110150862
2011-06-23

INHIBITORS OF STIM1 FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS

#7648
20110150832
2011-06-23

Furin-knockdown bi-functional RNA

#7649
20110144184
2011-06-16

Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhibitor or an inhibitor of LSD1 and a MAO inhibitor

#7650
20110144183
2011-06-16

Oligonucleotides for treating inflammation and neoplastic cell proliferation

#7651
20110143435
2011-06-16

Polymeric carrier

#7652
20110143434
2011-06-16

Diblock copolymers and polynucleotide complexes thereof for delivery into cells

#7653
20110143400
2011-06-16

SIRNA AND METHODS OF MANUFACTURE

#7654
20110142921
2011-06-16

RNAi therapeutic for treatment of hepatitis C infection

#7655
20110142917
2011-06-16

Compositions and methods for treatment of ear disorders

#7656
20110142915
2011-06-16

Compositions and methods for inhibition of VEGF

#7657
20110142820
2011-06-16

Targets for regulation of angiogenesis

#7658
20110142815
2011-06-16

Compounds, composition, methods, targets for cancer therapy

#7659
20110142767
2011-06-16

RNAi-mediated inhibition of tumor necrosis factor α-related conditions

#7660
20110136233
2011-06-09

NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF

#7661
20110135656
2011-06-09

Method of treating cancer

#7662
20110135654
2011-06-09

Prostate cancer related gene STYK1

#7663
20110135647
2011-06-09

Genes and polypeptides relating to breast cancers

#7664
20110135632
2011-06-09

Methods for the modulation of angiogenesis

#7665
20110135613
2011-06-09

METHODS FOR TREATING APOLIPOPROTEIN E4-ASSOCIATED DISORDERS

#7666
20110135597
2011-06-09

Methods of treating cutaneous ulcers and grafts using agonist antibodies to IL-23 receptor

#7667
20110135579
2011-06-09

RNAi-related inhibition of TNFα signaling pathway for treatment of glaucoma

#7668
20110131687
2011-06-02

Polypeptides having arabinofuranosidase activity and polynucleotides encoding same

#7669
20110131668
2011-06-02

IMPROVED GENE SILENCING METHODS

#7670
20110130443
2011-06-02

Compositions and methods for inhibiting expression of factor V

#7671
20110129527
2011-06-02

RAB3B for treatment and prevention of Parkinson's disease

#7672
20110129482
2011-06-02

POLYPEPTIDE COMPOUNDS FOR INHIBITING ANGIOGENESIS AND TUMOR GROWTH

#7673
20110129465
2011-06-02

Mammalian receptor protein DCRS5; methods of treatment

#7674
20110129461
2011-06-02

MAT II β subunit RNAi and therapeutic methods using same

#7675
20110129450
2011-06-02

METHOD OF PROMOTING NEUROGENESIS BY MODULATING SECRETASE ACTIVITIES

#7676
20110126321
2011-05-26

Recombinant DNA for gene suppression

#7677
20110125075
2011-05-26

METHOD FOR CONTROL OF ELECTROPORATION APPARATUS

#7678
20110124711
2011-05-26

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Nav1.8 GENE

#7679
20110124708
2011-05-26

RNAI-MEDIATED INHIBITION OF OCULAR HYPERTENSION TARGETS

#7680
20110124707
2011-05-26

Methods and compositions for reducing viral genome amounts in a target cell

#7681
20110124108
2011-05-26

EPIGENETIC ENGINEERING

#7682
20110124099
2011-05-26

IKKALPHA AND IKKBETA SPECIFIC INHIBITORS

#7683
20110123538
2011-05-26

COMPOSITION COMPRISING EXPRESSION OR ACTIVITY INHIBITORS OF NINJURIN 1 FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASE

#7684
20110123520
2011-05-26

Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components

#7685
20110119781
2011-05-19

Compositions and Methods for Inhibiting Expression of TGF-BETA Receptor Genes

#7686
20110118456
2011-05-19

Interfering RNA molecules

#7687
20110118340
2011-05-19

DELIVERY OF RNAI CONSTRUCTS TO OLIGODENDROCYTES

#7688
20110118339
2011-05-19

CHEMICALLY MODIFIED OLIGONUCLEOTIDES AND USES THEREOF

#7689
20110118337
2011-05-19

Method of Using Compositions Comprising MIR-192 and/or MIR-215 for the Treatment of Cancer

#7690
20110118335
2011-05-19

RNA Interference Mediated Inhibition Of Gene Expression Using Multifunctional Short Interfering Nucleic Acid (Multifunctional siNA)

#7691
20110118333
2011-05-19

Use on minicircle vectors for cardiac gene therapy

#7692
20110118331
2011-05-19

Cationic siRNAs, synthesis and use for RNA interference

#7693
20110118140
2011-05-19

METHODS FOR IDENTIFICATION, AND COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES

#7694
20110117627
2011-05-19

REGULATION OF APOPTOSIS BY NEURAL SPECIFIC SPLICE VARIANTS OF IG20

#7695
20110117608
2011-05-19

DOUBLE-STRANDED NUCLEIC ACID

#7696
20110117188
2011-05-19

Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof

#7697
20110117183
2011-05-19

Therapeutic RNA interference technology targeted to the PDX-1 oncogene in PDX-1 expressing neuroendocrine tumors

#7698
20110117106
2011-05-19

USES OF CALPAIN INHIBITORS TO INHIBIT INFLAMMATION

#7699
20110117102
2011-05-19

Therapeutic uses of inhibitors of RTP801

#7700
20110117094
2011-05-19

Reactivation of axon growth and recovery in chronic spinal cord injury

#7701
20110117090
2011-05-19

ADAM-15 antibodies and immunogenic peptides

#7702
20110117053
2011-05-19

METHOD OF MODULATING FIBROBLAST ACCUMULATION OR COLLAGEN DEPOSITION

#7703
20110112284
2011-05-12

Methods for modulating IKKα activity

#7704
20110112283
2011-05-12

RNA interference mediating small RNA molecules

#7705
20110112178
2011-05-12

Compositions and methods for inhibiting expression of IKK-B gene

#7706
20110112176
2011-05-12

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF KIF10 GENES

#7707
20110112173
2011-05-12

Methods and compositions involving microRNA

#7708
20110112170
2011-05-12

Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicity

#7709
20110112169
2011-05-12

RNAi-BASED THERAPEUTICS FOR ALLERGIC RHINITIS AND ASTHMA

#7710
20110112168
2011-05-12

Double-stranded RNA directed to CASP2 and methods of use thereof

#7711
20110111983
2011-05-12

siRNA targeting spleen tyrosine kinase

#7712
20110111501
2011-05-12

Complex of polysaccharide and double-stranded RNA

#7713
20110111493
2011-05-12

Compositions and methods for inhibiting expression of a target gene

#7714
20110111491
2011-05-12

RNA interference suppresion of neurodegenerative diseases and methods of use thereof

#7715
20110111056
2011-05-12

PEPTIDE DICER SUBSTRATE AGENTS AND METHODS FOR THEIR SPECIFIC INHIBITION OF GENE EXPRESSION

#7716
20110111041
2011-05-12

Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells

#7717
20110110896
2011-05-12

Modulating levels of RNA-binding proteins for the treatment of breast cancer

#7718
20110110860
2011-05-12

MODULATION OF LDL RECEPTOR GENE EXPRESSION WITH DOUBLE-STRANDED RNAS TARGETING THE LDL RECEPTOR GENE PROMOTER

#7719
20110105593
2011-05-05

MicroRNA-Formatted Multitarget Interfering RNA Vector Constructs and Methods of Using The Same

#7720
20110105591
2011-05-05

siRNA compounds for inhibiting NRF2

#7721
20110105588
2011-05-05

COMPOSITIONS COMPRISING NOTCH1 SIRNA AND METHODS OF USE THEREOF

#7722
20110105584
2011-05-05

RTP80IL SIRNA COMPOUNDS AND METHODS OF USE THEREOF

#7723
20110105583
2011-05-05

Methods of using MIR34 as a biomarker for TP53 functional status

#7724
20110105363
2011-05-05

siRNA targeting TNFa

#7725
20110104255
2011-05-05

THERAPEUTIC AGENT FOR FIBROID LUNG

#7726
20110104181
2011-05-05

Treatment of neuropathic pain using anti-thrombospondin antibodies

#7727
20110098460
2011-04-28

siRNA useful to supress expression of EIF-5A1

#7728
20110098339
2011-04-28

C2ORF18 AS TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS

#7729
20110098338
2011-04-28

RNA interference for the treatment of heart failure

#7730
20110098337
2011-04-28

Inhibitors of RTP801 and their use in disease treatment

#7731
20110098200
2011-04-28

Methods using dsdna to mediate rna interference (rnai)

#7732
20110097720
2011-04-28

SCREENING METHOD FOR SELECTED AMINO LIPID-CONTAINING COMPOSITIONS

#7733
20110097707
2011-04-28

RNAi Agents Comprising Universal Nucleobases

#7734
20110097390
2011-04-28

Ultra-small RNAs as toll-like receptor-3 antagonists

#7735
20110097338
2011-04-28

Use of Substances for Sensitization of Tumor Cells to Radiation and/or Chemotherapy

#7736
20110097335
2011-04-28

ABC TRANSPORTER PROTEIN EXPRESSION INHIBITOR

#7737
20110097329
2011-04-28

COMPOSITIONS AND METHODS FOR TREATING CANCER AND MODULATING STRESS GRANULE FORMATION

#7738
20110097328
2011-04-28

Methods and compositions for increasing the activity of inhibitory RNA

#7739
20110092575
2011-04-21

SIRNA OF HUMAN OSTEOPONTIN

#7740
20110092571
2011-04-21

Compositions and methods for siRNA inhibition of ICAM-1

#7741
20110092568
2011-04-21

MODULATION OF MLCK-L EXPRESSION AND USES THEREOF

#7742
20110092567
2011-04-21

Cannabinoid 2 (CB) receptor gene promoter and unique RNA transcripts in B cells and methods of use

#7743
20110092565
2011-04-21

METHOD OF TREATING NEURODEGENERATIVE DISEASE

#7744
20110091523
2011-04-21

Cochleate compositions directed against expression of proteins

#7745
20110088124
2011-04-14

Reduction of -phosphatidylcholine acyltransferase activity

#7746
20110086425
2011-04-14

DELIVERY OF siRNAs

#7747
20110086089
2011-04-14

USE OF P27KIP1 FOR THE PREVENTION AND TREATMENT OF HEART FAILURE

#7748
20110086044
2011-04-14

Compositions and Methods to Inhibit HPV Infection

#7749
20110086043
2011-04-14

STAT5a and its functional tumor suppressor analogs for treatment of malignancies expressing NPM/ALK and other oncogenic kinases

#7750
20110083232
2011-04-07

Maize microrna sequences

#7751
20110082185
2011-04-07

CANCER-TESTIS GENE SILENCING AGENTS AND USES THEREOF

#7752
20110081717
2011-04-07

Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of cancer

#7753
20110081362
2011-04-07

TREATMENT OF CANCER

#7754
20110081331
2011-04-07

Therapy of p53 mutant colon adenocarcinoma, breast cancer and lung cancer

#7755
20110078946
2011-04-07

Compositions and methods for promoting fatty acid production in plants

#7756
20110078829
2011-03-31

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

#7757
20110077702
2011-03-31

Means and Methods for Influencing Electrical Activity of Cells

#7758
20110077286
2011-03-31

Oligonucleotide duplexes comprising DNA-like and RNA-like nucleotides and uses thereof

#7759
20110077284
2011-03-31

DRY POWDER COMPOSITIONS FOR RNA INFLUENZA THERAPEUTICS

#7760
20110077173
2011-03-31

siRNA targeting tie-2

#7761
20110076335
2011-03-31

Lipid formulations for nucleic acid delivery

#7762
20110076272
2011-03-31

THERAPEUTIC METHODS AND COMPOSITIONS

#7763
20110076251
2011-03-31

NOVEL THERAPEUTIC AGENTS AGAINST HEPATITIS

#7764
20110071211
2011-03-24

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

#7765
20110071209
2011-03-24

RNAi Modulation of the RHO-A Gene and Uses Thereof

#7766
20110071208
2011-03-24

LIPID ENCAPSULATED DICER-SUBSTRATE INTERFERING RNA

#7767
20110070653
2011-03-24

Inhibitor of histone acetyltransferase, especially p300

#7768
20110070245
2011-03-24

IMP-1 ONCOGENE AS A THERAPEUTIC TARGET AND PROGNOSTIC INDICATOR FOR LUNG CANCER

#7769
20110070240
2011-03-24

Methods of treating B-cell cancers

#7770
20110070234
2011-03-24

NP1 ACTIVITY REGULATING ELEMENTS USEFUL FOR THE PRODUCTION OF DRUGS FOR THE TREATMENT OR PREVENTION OF HUMAN NEURODEGENERATIVE DISEASES, RESULTING DRUGS AND USE THEREOF

#7771
20110070221
2011-03-24

mutations in melanoma

#7772
20110070162
2011-03-24

RNA interference mediating small RNA molecules

#7773
20110065908
2011-03-17

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA

#7774
20110065807
2011-03-17

PH sensitive biodegradable polymeric particles for drug delivery

#7775
20110065778
2011-03-17

RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)

#7776
20110065777
2011-03-17

DOUBLE-STRANDED RNA (dsRNA) AND METHOD OF USE FOR INHIBITING EXPRESSION OF A FUSION GENE

#7777
20110065773
2011-03-17

RNA interference mediating small RNA molecules

#7778
20110065772
2011-03-17

TREATMENT OF RHEUMATOID ARTHRITIS

#7779
20110065644
2011-03-17

COMPOSITIONS COMPRISING HUMAN PCSK9 AND APOLIPOPROTEIN B SIRNA AND METHODS OF USE

#7780
20110065109
2011-03-17

RNA interference mediating small RNA molecules

#7781
20110065087
2011-03-17

NOVEL HIV TARGETS

#7782
20110064792
2011-03-17

Method for opening tight junctions

#7783
20110064724
2011-03-17

Methods for identifying compounds for the treatment of type 1 diabetes

#7784
20110064664
2011-03-17

METHODS AND COMPOSITIONS INVOLVING CHITOSAN NANOPARTICLES

#7785
20110060123
2011-03-10

CHARGE CONVERSIONAL TERNARY POLYPLEX

#7786
20110060032
2011-03-10

Lipid encapsulating interfering RNA

#7787
20110060031
2011-03-10

Compositions and methods for inhibiting expression of a gene from the ebola virus

#7788
20110060028
2011-03-10

COMBINATION THERAPY

#7789
20110059531
2011-03-10

Method for expression of small RNA molecules within a cell

#7790
20110059187
2011-03-10

PEPTIDE DICER SUBSTRATE AGENTS AND METHODS FOR THEIR SPECIFIC INHIBITION OF GENE EXPRESSION

#7791
20110059111
2011-03-10

MAMMALIAN RECEPTORS AS TARGETS FOR ANTIBODY AND ACTIVE VACCINATION THERAPY AGAINST MOLD INFECTIONS

#7792
20110059094
2011-03-10

ANTITUMOR EFFECTS OF INSULIN-RESPONSIVE DNA BINDING PROTEIN-1 (IRDBP-1)

#7793
20110055965
2011-03-03

CYCLE SINGLE-STRANDED NUCLEIC ACID COMPLEX AND METHOD FOR PRODUCING THE SAME

#7794
20110055941
2011-03-03

Chd5 is a novel tumor suppressor gene

#7795
20110054160
2011-03-03

Therapeutic compositions

#7796
20110054159
2011-03-03

RNA interference mediating small RNA molecules

#7797
20110054008
2011-03-03

RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma

#7798
20110054005
2011-03-03

Polynucleotides for causing RNA interference and method for inhibiting gene expression using the same

#7799
20110053862
2011-03-03

COMPOSITIONS COMPRISING SURVIVIN SIRNA AND METHODS OF USE THEREOF

#7800
20110053861
2011-03-03

COMPOSITIONS COMPRISING NUCLEAR FACTOR-KAPPA B (NF-KB) SIRNA AND METHODS OF USE